Clinical Study

PRE-CLINICAL TRIAL PHASE

Tempo

Brain-Computer Interface

High-data-rate
BCI applications for active users

Our Purpose

Empowering people on the move

Up to now, advanced brain-computer interface (BCI) capabilities have largely been designed for users with limited mobility. Tempo BCI will change that.

Designed for ambulatory individuals, Tempo BCI will expand the scope of BCI applications dramatically.

With unprecedented brain activity capture, Paradromics is exploring advanced applications for active individuals: speech restoration, computer control, and upper limb prosthetic control – alongside the possibility of continuous brain-state monitoring for mental health, enabling data-driven personalized treatments based on closed-loop, real-time feedback.

Introducing Tempo BCI

Disclaimer: Tempo BCI is in a pre-clinical trial phase.

More channels, more data, more life

Engineered for higher data rates, broader indications, and the demands of an active life.

Rechargeable, reliable, & ready when you are

Completely concealed, wireless, and powered by a rechargeable battery, the Tempo BCI is designed to move through the world with you — paired with a discreet wearable companion device.

Moore’s law for the brain

Our next generation device will have more than 2x the number of electrode channels in the same size package. With ~1,000 microelectrodes per cortical module, Tempo BCI will read brain data at even higher resolution than our already best-in-class Connexus BCI.

Expanded applications

Multi-region, high-bandwidth brain recording expands the range of conditions that Tempo BCI can address, including new applications for neurological conditions that have long lacked access to real-time neural data.

Built to last

With every new generation of device, our commitment to durability and safety will remain the same. Medically proven materials. Waterproof electronics. Wireless power and data transmission. Every design choice prioritizes longevity because every BCI user deserves a device that is engineered to last as long as needed.

With each new brain area we gain access to, we have the potential to open up a new set of applications. We start where the need is greatest: people for whom no adequate treatments exist today, but the infrastructure that we are building will not only restore human abilities — it will create new ones entirely.”

Matt Angle

paradromics Founder and CEO